And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been ...

All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

FDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.

FDA Commissioner Marty Makary said that one of his key priorities is to modernize the agency by streamlining the drug review ...

The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans’ genetic data to international labs. Based on “mounting evidence,” the FDA said ...

Food and Drug Administration Commissioner Marty Makary announced that the agency intends to fast-track reviews for certain ...

Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory ...

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...

The U.S. Food and Drug Administration (FDA) today announced an immediate halt to new clinical trials that were shipping ...